iSpecimen Inc.
ISPC
$5.62
$0.397.46%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -79.24% | -67.73% | -43.77% | -13.05% | -6.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -79.24% | -67.73% | -43.77% | -13.05% | -6.42% |
| Cost of Revenue | -64.08% | -51.34% | -24.11% | 6.14% | 10.01% |
| Gross Profit | -99.40% | -85.50% | -63.36% | -32.56% | -21.92% |
| SG&A Expenses | -48.11% | -8.29% | -13.99% | -10.15% | 3.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.47% | -23.16% | -18.50% | -7.04% | 4.37% |
| Operating Income | 29.46% | -24.31% | -7.40% | 2.25% | -13.96% |
| Income Before Tax | 16.09% | -21.09% | 0.03% | 2.73% | -12.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.09% | -21.09% | 0.03% | 2.73% | -12.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.09% | -21.09% | 0.03% | 2.73% | -12.60% |
| EBIT | 29.46% | -24.31% | -7.40% | 2.25% | -13.96% |
| EBITDA | 30.09% | -24.89% | -7.16% | 2.86% | -13.35% |
| EPS Basic | 87.11% | 63.29% | 60.13% | 53.43% | 28.67% |
| Normalized Basic EPS | 87.11% | 63.29% | 60.13% | 53.43% | 28.67% |
| EPS Diluted | 87.11% | 63.29% | 60.13% | 53.43% | 28.67% |
| Normalized Diluted EPS | 87.11% | 63.29% | 60.13% | 53.43% | 28.67% |
| Average Basic Shares Outstanding | 546.42% | 444.74% | 243.83% | 160.04% | 57.65% |
| Average Diluted Shares Outstanding | 546.42% | 444.74% | 243.83% | 160.04% | 57.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |